Innovating Works

ABBVIE INC

Desconocido
OPTIMA: Optimal treatment for patients with solid tumours in Europe through Artificial intelligence ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2020-23-two-stage OPTIMA is a multi-stakeholder-led consortium with the vision that each and every patient should have access to the most up-to-date individua...
2021-10-18 - 2026-09-30 | Financiado
RealHOPE: Real World Handling of Protein Drugs Exploration Evaluation and Education ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2020-20-two-stage RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients...
2021-07-05 - 2025-06-30 | Financiado
HARMONY PLUS: HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY PLUS ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2019-19-single-stage Haematological malignancies (HM), also known as blood cancers, are a heterogeneous and complex group of multicausal diseases that can’t be e...
2020-05-26 - 2024-03-31 | Financiado
Trials@Home: Trials@Home Center of Excellence Remote Decentralised Clinical Trials ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2018-14-two-stage Clinical trials increase in size, complexity and costs. This is fuelled with the need to demonstrate effects in more complex therapeutic are...
2019-08-07 - 2025-11-30 | Financiado
EHDEN: European Health Data and Evidence Network ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2017-12-two-stage Europe is generating huge amounts of patient-level information contained in Electronic Health Record (EHR) systems and other types of health...
2018-11-22 - 2024-10-31 | Financiado
WEB-RADR 2: WEB RADR 2 ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2017-11-single-stage This proposal seeks to build on the mobile application (app) functionality delivered through the original WEB-RADR project to expand access...
2018-09-10 - 2020-06-30 | Financiado
EFOEUPATI: Ensuring the future of EUPATI beyond 2020 ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2017-11-single-stage The European Patients' Academy on Therapeutic Innovation (EUPATI) IMI project resulted in a number of key outputs for the field of patient e...
2018-06-21 - 2020-09-30 | Financiado
eTRANSAFE: Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2016-09-two-stage Drug safety assessment is a knowledge-intensive process that demands advancement in data handling methods and tools for facilitating data sh...
2017-09-12 - 2023-02-28 | Financiado
HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY Sofia ref.... ABBVIE INC participó en un H2020 H2020-JTI-IMI2-2015-06-two-stage Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in qual...
2016-12-22 - 2023-06-30 | Financiado
PREDECT: New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours ABBVIE INC participó en un FP7 Traditional preclinical discovery methods, particularly for target validation, poorly predict drug efficacy, causing a high attrition rate i...
Financiado
APPROACH: Applied Public Private Research enabling OsteoArthritis Clinical Headway ABBVIE INC participó en un FP7 The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharm...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.